HyperglycemiaHypoglycemiaBlood GlucoseDiabetic KetoacidosisInsulinHospitalizationDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Diabetes MellitusIslets of LangerhansGlucoseHypoglycemic AgentsDiabetes Mellitus, Type 1GlucagonHyperinsulinismStreptozocinGlucose Tolerance TestHemoglobin A, GlycosylatedGlucose Clamp TechniqueC-PeptideFastingTime FactorsInsulin ResistanceEpinephrineInsulin-Secreting CellsPostprandial PeriodDiabetes ComplicationsGluconeogenesisRisk FactorsInsulin Infusion SystemsBlood Glucose Self-MonitoringRetrospective StudiesDiabetic AngiopathiesInsulin, Long-ActingGlucokinasePancreatic PolypeptideGlycosuriaPhlorhizinTreatment OutcomeLength of StayPregnancy in DiabeticsGlucose IntoleranceLiverRats, Sprague-DawleyBody WeightAcute DiseaseInfant, NewbornDiabetic NephropathiesGlucagon-Like Peptide 1Critical IllnessPancreasFatty Acids, NonesterifiedProspective StudiesHyperglycemic Hyperosmolar Nonketotic ComaRats, WistarInpatientsCohort StudiesInfusions, IntravenousSulfonylurea CompoundsDisease Models, AnimalReference ValuesObesityHomeostasisAlloxanRats, ZuckerPancreas, ArtificialUnited StatesGlipizideInsulin ComaDiabetic NeuropathiesIncidenceHydrocortisoneOxidative StressClinical AlarmsMice, Inbred C57BLAcarboseMetforminFollow-Up StudiesChoreaIslets of Langerhans TransplantationHyperglycinemia, NonketoticGlycogenSeverity of Illness IndexDiabetic RetinopathyGlucose Transporter Type 2InsulinomaGlucagon-Secreting CellsDiazoxidePancreatectomyPrediabetic StateDiabetic Coma3-Hydroxybutyric AcidLiver GlycogenLactatesDipeptidyl-Peptidase IV InhibitorsSomatostatinDose-Response Relationship, DrugLactic AcidGlycosylation End Products, AdvancedAge Factors